Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Genetic Epilepsy v0.2233 SERAC1 Zornitza Stark Classified gene: SERAC1 as Green List (high evidence)
Genetic Epilepsy v0.2233 SERAC1 Zornitza Stark Gene: serac1 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.2207 SERAC1 Elena Savva Marked gene: SERAC1 as ready
Genetic Epilepsy v0.2207 SERAC1 Elena Savva Gene: serac1 has been classified as Amber List (Moderate Evidence).
Genetic Epilepsy v0.2207 SERAC1 Elena Savva Classified gene: SERAC1 as Amber List (moderate evidence)
Genetic Epilepsy v0.2207 SERAC1 Elena Savva Gene: serac1 has been classified as Amber List (Moderate Evidence).
Genetic Epilepsy v0.2206 SERAC1 Elena Savva gene: SERAC1 was added
gene: SERAC1 was added to Genetic Epilepsy. Sources: Literature
Mode of inheritance for gene: SERAC1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SERAC1 were set to PMID: 27186703; 24997715
Phenotypes for gene: SERAC1 were set to 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome MIM#614739
Review for gene: SERAC1 was set to AMBER
Added comment: Seizures (less common) listed in OMIM

PMID: 27186703 - two sibling patients who presented with 3-methylglutaconic acid and 3-methylglutaric aciduria, microcephaly, growth retardation, dysmorphic features, severe sensorineural deafness, progressive spasticity, dystonia, seizures and basal ganglia involvement.

PMID: 24997715 - Proband with biallelic PTCs, presented with 3-methylglutaconic aciduria, sensorineural hearing loss, encephalopathy, and Leigh-like pattern on MRI, as well as developmental delay and developmental regression, bilateral optic nerve atrophy, microcephaly, and myoclonic epilepsy.

GeneReviews - 38% of patients have seizures (febrile, myoclonic)
Sources: Literature